Medical research without adequate pre-publication review could damage public trust in medical science
The public could lose trust in science if scientific and medical researchers choose to bypass the traditional high standards of peer-reviewed medical journals in the rush to get research data released, particularly during crises such as the COVID-19 pandemic.
That’s the warning from 3 leading medical communications organisations, that have published a joint statement in the peer-reviewed journal Current Medical Research and Opinion – asserting that the integrity of published scientific and medical research must be protected.
Published last week, the joint statement from the American Medical Writers Association (AMWA), the European Medical Writers Association (EMWA), and the International Society for Medical Publication Professionals (ISMPP), argues that although peer-review is still the most common process for vetting scientific publications, there is a worrying trend for manuscripts to be released without pre-publication review.
Especially during the COVID-19 health crisis, medical researchers have felt significant pressure to publish COVID-19 findings as quickly as possible, but the statement emphasises that having a pre-publication review is still essential. The danger is that once the threshold of publication oversight is lowered, it becomes a precedent that cannot be easily reversed, potentially eroding standards and causing the public to lose trust in medical science.
“Medical communicators, including writers, editors, and those involved in quality control, play a critical role in ensuring that clinical and scientific data are published and disseminated in an accurate and clear manner. In the current rush-to-publish environment, all stakeholders in the scientific and clinical research communities and press must ensure that the public have correct and actionable information from which to make health and medical decisions,” explained Gail Flores, PhD, President of AMWA.
In particular, the statement highlights the impact of preprints – preliminary scientific reports that are made publicly available online for anyone to read and discuss before they have been peer reviewed. While preprints enable rapid release and discussion of data, many are never revised or corrected, and only about a third to a half are ever fully published. This can also occur with articles submitted for post-publication peer review, in which an article is published in its original form, before expert peer reviewers are invited to critique it.
The statement recognises the benefit of rapid publication but alerts that they have to be vetted against the potential harms associated with an accelerated process.
“Particularly in these times, it is more important than ever to retain public trust in science, while balancing the need to report timely and relevant medical research,” stated Beatrix Doerr, PhD, President of EMWA.
In seeking a resolution, the 3 organisations present recommendations and a Reviewers’ Checklist to provide a minimum standard of pre-publication vetting to enhance preprint publication processes.
Their key recommendations include:
- performing more extensive and consistent checks ̶ for example, by preprint server hosts ̶ – on articles that have not been peer-reviewed prior to publication
- referencing preprints and articles uploaded for post-publication peer-review only as in-text reference (with a preprint link, DOI, or both), rather than as a bibliographic reference, and clearly labelled as a preprint, or as undergoing post-publication peer review
- watermarking articles plus including a disclosure within the body of the article highlighting that the findings have not been formally peer-reviewed
- educating medical journalists and the public about the differences between preprints, post-publication peer review, and traditional peer review.
Crucially, the organisations have also identified ways in which the peer-review process – renowned for being “laborious and time-consuming” – could be expedited. They call upon each stakeholder – authors, journal editors, and publishers – to play a part in this. Their key suggestions include:
- rapid response team of reviewers
- standardised formatting requirements to shorten the time to re-submission
- portable peer-review
- fast-track options
- incentives for reviewers
“For those engaged in preprints, post-publication peer-review, as well as traditional peer-review publications, our joint statement presents key practical recommendations to safeguard the quality of the publications while supporting their more rapid dissemination. We strongly encourage authors, journal editors, publishers, and other stakeholders to review and apply these practical suggestions, ensuring a high-quality standard for published research, irrespective of the format,” emphasized Robert J. Matheis, PhD, MA, President and CEO of ISMPP.
To arrange an interview, please contact:
Anna Geraci, Director of Communications, ISMPP
For further information:
Simon Wesson, Press & Media Executive
Tel.: +44 (0)20 7017 4311
Follow us on Twitter: @tandfnewsroom
About AMWA: The American Medical Writers Association (AMWA) is a not-for-profit organization promoting excellence in medical communication and providing educational resources in support of that goal. AMWA’s over 4,300 members are committed to accurately and ethically making information about health and medicine clear and meaningful. www.amwa.org
About EMWA: The European Medical Writers Association (EMWA) is an association committed to representing, supporting and training medical communication professionals. It has more than 1,200 members from all over Europe and beyond, representing all sectors of medical writing. EMWA is a not-for-profit organization, run by its members for its members. www.emwa.org
About ISMPP: The International Society for Medical Publication Professionals (ISMPP) is a not-for-profit organization established in 2005, that exists to advance the medical publication and communication professions globally. ISMPP comprises more than 1,800 members, with representation from all stakeholders involved in the publication and communication of medical research. www.ismpp.org
About Taylor & Francis Group
Taylor & Francis Group partners with researchers, scholarly societies, universities and libraries worldwide to bring knowledge to life. As one of the world’s leading publishers of scholarly journals, books, ebooks and reference works our content spans all areas of Humanities, Social Sciences, Behavioural Sciences, Science, and Technology and Medicine.
From our network of offices in Oxford, New York, Philadelphia, Boca Raton, Boston, Melbourne, Singapore, Beijing, Tokyo, Stockholm, New Delhi and Cape Town, Taylor & Francis staff provide local expertise and support to our editors, societies and authors and tailored, efficient customer service to our library colleagues.
With thanks to our sponsor, Aspire Scientific Ltd
Leave a Reply